Slide 1: Coloplast Earnings Conference Call 9M 2018/19
Coloplast Earnings Conference Call 9M 2018/19 14 August 2019
Slide 2: Forward-looking statements
Forward-looking statements The forward-looking statements contained in this presentation, including forecasts of sales and earnings performance, are not guarantees of future results and are subject to risks, uncertainties and assumptions that are difficult to predict. The forward-looking statements
Slide 3: Coloplast delivered Q3 organic growth of 8% and an EBIT margin of 31%
Coloplast delivered Q3 organic growth of 8% and an EBIT margin of 31% Q3 Highlights Revenue growth +9% • Organic growth of 8% and 9% in DKK Reported revenue (DKKm) +8% • Continued strong momentum in Europe across all business Organic growth 13,321 areas and double digit growth in Chronic Care in the
Slide 4: Solid growth across all business areas in Europe, US and China
Solid growth across all business areas in Europe, US and China 9M 18/19 revenue by business area 9M 18/19 revenue by geography Business Reported revenue Organic growth Share of organic Geographic Reported revenue Organic growth Share of organic area DKKm growth area DKKm growth Ostomy Care 5,317 7%
Slide 5: 9M 18/19 reported revenue grew 9% driven by solid organic growth of 8%
9M 18/19 reported revenue grew 9% driven by solid organic growth of 8% Comments Revenue development • 9M 2018/19 reported revenue increased by DKK (DKKm) 1,106m or 9% compared to 9M 2017/18 95 13,321 • The majority of growth was driven by organic growth 956 55 contributing DKK 956m or 8% to reported
Slide 6: Solid growth in EBIT of 11% in 9M and 13% in Q3
Solid growth in EBIT of 11% in 9M and 13% in Q3 Comments EBIT margin development (%) • EBIT increased 11% to DKK 4,077m with a reported margin of 31% compared to 30% last year • Gross margin of 67% in DKK compared to 67% same period last year 0.1 -0.2 0.0 30.6 0.0 30.6 0.0 • Positive impact from ope
Slide 7: Unchanged guidance for FY 2018/19
Unchanged guidance for FY 2018/19 Guidance 2018/19 Guidance 2018/19 (DKK)* Key assumptions • Up to 1% negative price pressure from Switzerland, Holland and Sales growth ~8% ~9% the French price reform (organic) • DKK guidance includes growth from Lilial and IncoCare • Incremental investments of 1-2%
Slide 8: Our mission, values and vision
Our mission Making life easier for peoplé with intimate healthcare needs Our values Closeness... to better understand. - Passion... to make a difference Respect and responsibility... to 0 guide | US: Our vision Setting the global standard for listening and responding: Coloplast Group - Ostomy Care /